Scynexis (SCYX) Accumulated Expenses (2013 - 2026)
Scynexis' (SCYX) quarterly Accumulated Expenses came in at $1.5 million in Q1 2026, down 41.86% YoY from $2.6 million in Q1 2025, and up 1.46% on a QoQ basis from $1.5 million in Q4 2025.
Scynexis (SCYX) Accumulated Expenses (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Accumulated Expenses data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Accumulated Expenses fell 41.86% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 41.86% YoY) and the FY2025 annual result came in at $1.5 million, down 60.27% from the prior year.
- Accumulated Expenses climbed to $1.5 million in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $9.5 million in Q3 2023 to a low of $453000.0 in Q1 2024.
- A 5-year average of $3.3 million and a median of $2.5 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Accumulated Expenses soared 944.57% — and 2024, when it plunged 90.51%.
- Tracing SCYX's Accumulated Expenses over 5 years: stood at $5.6 million in 2022, then slumped by 69.94% to $1.7 million in 2023, then jumped by 124.17% to $3.8 million in 2024, then slumped by 60.27% to $1.5 million in 2025, then increased by 1.46% to $1.5 million in 2026.
- The last three Accumulated Expenses figures came in at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Scynexis | 60.54 Mn | -54.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.03 Mn |
| Mar 31, 2026 | 1.53 Mn |
| Dec 31, 2025 | 1.51 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 2.48 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | 3.79 Mn |
| Sep 30, 2024 | 1.34 Mn |
| Jun 30, 2024 | 5.50 Mn |
| Mar 31, 2024 | 453,000.00 |
| Dec 31, 2023 | 1.69 Mn |
| Sep 30, 2023 | 9.54 Mn |
| Jun 30, 2023 | 7.19 Mn |
| Mar 31, 2023 | 4.78 Mn |
| Dec 31, 2022 | 5.63 Mn |
| Sep 30, 2022 | 1.82 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 5.70 Mn |
| Sep 30, 2021 | 1.51 Mn |